Satsuma Pharmaceuticals Inc (STSA)
NASDAQ:STSA
Holding STSA?
Track your performance easily

Satsuma Pharmaceuticals (STSA) Income Statement

0 Followers

Satsuma Pharmaceuticals Income Statement

Last quarter (Q ), Satsuma Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Satsuma Pharmaceuticals's net income was $-10.27M. See Satsuma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
--$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 18.98M$ -70.95M$ 51.17M$ 48.33M$ 28.88M$ 7.51M
Operating Income
$ -54.44M$ -59.22M$ -51.17M$ -48.33M$ -28.88M$ -7.51M
Net Non Operating Interest Income Expense
$ 1.34M$ 892.00K$ -6.00K$ 765.00K$ 707.00K$ -18.00K
Other Income Expense
$ 11.64M$ 11.69M$ -71.00K-$ -1.00K$ 187.00K
Pretax Income
$ -64.75M$ -70.01M$ -51.17M$ -47.56M$ -28.18M$ -7.35M
Tax Provision
$ -953.00K$ -953.00K----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -64.75M$ -70.01M$ -51.17M$ -47.56M$ -28.18M$ -7.35M
Basic EPS
$ -2.50$ -2.19$ -1.75$ -2.73$ -4.80$ -1.08
Diluted EPS
$ -2.01$ -2.19$ -1.75$ -2.73$ -4.80$ -1.08
Basic Average Shares
$ 128.59M$ 32.02M$ 29.17M$ 17.41M$ 5.86M$ 6.80M
Diluted Average Shares
$ 128.59M$ 32.02M$ 29.17M$ 17.41M$ 5.86M$ 6.80M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 18.98M$ -70.95M$ 51.17M$ 48.33M$ 28.88M$ 7.51M
Net Income From Continuing And Discontinued Operation
$ -64.77M$ -70.01M$ -51.17M$ -47.56M$ -28.18M$ -7.35M
Normalized Income
$ -31.41M-$ -51.17M$ -47.56M$ -28.18M$ -7.35M
Interest Expense
$ 2.00K-$ 163.00K$ 350.00K$ 482.00K$ 90.00K
EBIT
$ -65.68M$ -70.91M$ -51.01M$ -47.21M$ -27.69M$ -7.26M
EBITDA
$ -65.54M$ -70.18M$ -50.62M$ -46.97M$ -27.55M$ -7.20M
Currency in USD

Satsuma Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis